ARNATAR THERAPEUTICS CURE FOR CAUSE

Live / Allowed — Fifth extension granted (statement of use) (as of 20 May 2026)

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 16 Sept 2022 filing date already counts against anyone who files later.

Record

Serial number
97594202
Mark type
Design + words
Filed
16 Sept 2022
Published for opposition
26 Sept 2023
Attorney of record
Andrew T. Rissler

Goods and services

  • Class 005 — Pharmaceuticals: Medicines, namely, medical preparations for preventing or treating cardiovascular and metabolic diseases, as well as rare genetic diseases

Owner

Prosecution history

  • 28 Aug 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 28 Aug 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
  • 28 Aug 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
  • 20 May 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 20 May 2026 — SOU EXTENSION 5 GRANTED
  • 18 May 2026 — SOU EXTENSION 5 FILED
  • 19 May 2026 — SOU TEAS EXTENSION RECEIVED
  • 20 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 20 Jan 2026 — SOU EXTENSION 4 GRANTED
  • 21 Nov 2025 — SOU EXTENSION 4 FILED
  • 16 Jan 2026 — SOU EXTENSION RECEIVED WITH TEAS PETITION
  • 16 Jan 2026 — NOTICE OF REVIVAL - E-MAILED
  • 16 Jan 2026 — PETITION TO REVIVE-GRANTED
  • 16 Jan 2026 — TEAS PETITION TO REVIVE RECEIVED
  • 22 Dec 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

View this trademark record on Rightsy